Lactoferrin in complex treatment of dental diseases

Makeeva I.M.; Smirnova T.N.; Chernousov A.D.; Romanchenko A.I.; Gol'dman1 I.L.; Sadchikova1 E.R.

doi:https://doi.org/

Makeeva I.M.

I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Moscow, Russia

Smirnova T.N.

Kafedra terapevticheskoĭ stomatologii Pervyĭ MGMU im. I.M. Sechenova

Chernousov A.D.

Institut biologii gena RAN

Romanchenko A.I.

Institut biologii gena RAN;
"Transgenbank"

Gol'dman1 I.L.

Institut biologii gena RAN;
"Transgenbank";
OOO "Transgenfarm"

Sadchikova1 E.R.

Institut biologii gena RAN;
"Transgenbank";
OOO "Transgenfarm"

Lactoferrin in complex treatment of dental diseases

Authors:

Makeeva I.M., Smirnova T.N., Chernousov A.D., Romanchenko A.I., Gol'dman1 I.L., Sadchikova1 E.R.

More about the authors

Journal: Stomatology. 2012;91(4): 66‑71

Read: 13729 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Makeeva IM, Smirnova TN, Chernousov AD, Romanchenko AI, Gol'dman1 IL, Sadchikova1 ER. Lactoferrin in complex treatment of dental diseases. Stomatology. 2012;91(4):66‑71. (In Russ.)

Подписка 2026 Стоматология (Stomatology)

Использование инфографики авторами научных работ

References:

Adonogianaki E., Moughal N.A., Kinane D.F. Lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal disease. J Clin Periodontol 1993; 20: 26-31.
Aguilera O., Andres M.T., Heath J., Fierro J.F., Douglas S.W.I. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol Med Microbiol 1998; 21: 29-36.
Alugupalli K.R., Kalfas S. Degradation of lactoferrin by periodontitis-associated bacteria. FEMS Microbiol Lett 1995; 145: 209-214.
Alugupalli K.R., Kalfas S. Inhibitory effect of lactoferrin on the adhesion of Actinobacillus actinomycetemcomitans and Prevotella intermedia to fibroblasts and epithelial cells. APMIS 1996; 103: 154-160.
Al-Zahrani M.S. Increased intake of dairy products is related to lower periodontitis prevalence. J Periodontol 2006; 77: 289-294.
Baveye S., Elass E., Mazurier J., Spik G., Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999; 37: 281-286.
Chierici R. Antimicrobial actions of lactoferrin. Adv Nutr Res 2011; 10: 247-269.
Davey M.E., Costerton J.W. Molecular genetics analyses of biofilm formation in oral isolates. Periodontology 2000; 42: 3-26.
De Lillo A., Teanpaisan R., Fierro J.F., Douglas C.W.I. Binding and degradation of lactoferrin by Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol Med Microbiol 1996; 14: 135-143.
Egashira M., Takayanagi T., Moriuschi M., Moriushi H. Acta Pediatrica 2007; 96: 1238-1244.
Ellison 3rd R.T., Giehl T.J., Lf Force F.V. Infect Immun 56: 2774-2781.
Famaud S., Evans R.W. Molecular Immun 2003; 40: 395-405.
Fine D.H., Furgang D. Lactoferrin iron levels affect attachment of Actinobacillus actinomycetemcomitans to buccal epithelial cells. J Periodontol 2002; 73: 616-623.
Fine D.H., Furgang D., Beydouin F. Lactoferrin iron levels are reduced in saliva of patients with localized aggressive periodontitis. J Periodontol 2002; 73: 624-630.
Fransson C., Mooney J., Kinane D.F., Berglundh T. Differences in the inflammatory response in young and old human subjects during the course of experimental gingivitis. J Clin Periodontol 1999; 6: 453-460.
Friedman S.A., Mandel I.D., Herrera M.S. Lysozyme and lactoferrin quantitation in the crevicular fluid. J Periodontol 1983; 54: 347-350.
Jenssen H., Hancock R.E.W. Biochimie 2009; 91: 19-29.
Jentsch H., Sievert Y., Gocke R. Lactoferrin and other markers from gingival crevicular fluids and saliva before and after periodontal treatment. J Clin Periodontol 2004; 31: 511-514.
Jordan W.J., Eskdale J., Lennon G.P., Pestoff R., Wu L., Fine D.H., Gallagher G. A nonconservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis. Genes Immun 2005; 6: 632-635.
Kalmar J.R., Arnold R.R. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun 1988; 56: 2552-2557.
Kirstila V., Lenander-Lumikari M., Soderling E., Tenovuo J. Effects of oral hygiene products containing lactoperoxidase, lysozyme, and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia: Acta Odontol Scand 1996; 54: 6: 391-397.
Komine K.-I., Kuroishi T., Ozawa A., Komine Y., Minami T., Shimauchi H., Sugawara S. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontits patients Mol Immunol 2007; 44: 1498-1508.
Kondo I., Kobayashi T., Wakabayashi H., Yamauchi K., Iwatsuki K., Yoshie H. Effects of oral administration of bovine lactoferrin on periodontitis patients. Jpn J Conserv Dent 2008; 51: 281-291.
Kuipers M.E., Beljaars L., Van Beek N., De Vries H.G., Heegsma J., Van Den Berg J.J.M., Meijer D.K.F., Swart P.J. Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida. Apmis, Volume 2002; 110: Issue 4: 290-298.
Legrand D., Pierct A., Elass E., Carpenter M., Marilltr S. Mazurier J Adv Exp Med Biol 2008; 606: 163-194.
Levay P.F., Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80: 252-267.
Masci J.R. Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme. AIDS 2000; 14: Issue 15: 2403-2404.
Marsh P.D. Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res 1992; 71: 1431-1438.
Mayanagi G., Kimura M., Nakaya S., Hirata H., Sakamoto M., Benno Y., Shimauchi H. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets: a double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2009; 36: 506-513.
Oo T.Z., Cole N., Garthwaite L., Willcox M.D.P., Zhu H. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection. J Antimicrob Chemother 2010; 65: 1243-1251.
Ozdemir B., Ozcan G., Karaduman B., Teoman Al., Ayhan E., Ozer N., Us D. Lactoferrin in gingival crevicular fluid and peripheral blood during. experimental gingivitis. Eur J Dent 2009; 3: 16-23.
Shi Y., Kong W., Nakayama K. Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis. J Biol Chem 2000; 275: 30002-30008.
Shimauchi H., Mayanagi G., Nakaya S., Minamibuchi M., Ito Y., Yamaki K., Hirata H. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 2008; 35: 897-905.
Shimazaki Y., Shirota T., Uchida K., Yonemoto K., Kiyohara Y., Iida M., Saito T., Yamashita Y. Intake of dairy products and periodontal disease: The Hisayama study. J Periodontol 2008; 79: 131-137.
Takakaura N., Wakabayashi H., Ishibashi H., Teraguchi S., Tamura Y., Yamaguchi H., Abe S. Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 2003; 47: 2619-2623.
Takakaura N., Wakabayashi H., Ishibashi H., Yamauchi K., Teraguchi S., Tamura Y., Yamaguchi H., Abe S. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 2004; 53: 6495-6500.
Teraguchi S., Wakabayashi H., Kuwata H., Yamauchi K., Tamura Y. Protection against infections by oral lactoferrin: Evaluation in animal models: BioMetals 2004; 17: 3: 231-234.
Van Der Berg J.J.M., Kuipers M.E., Van Beek N., De Vries-Hospers, Frijlink H.W., Meijer D.K.F., Swart P.J. Lactoferrin: structure, function and applications. Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications 1999.
Van Der Strate B.W., Harmsen M.C., The T.H. Plasma lactoferrin levels are decreased in end-stage AIDS patients. Viral Immunol 1999; 12: 197-203.
Velliyagounder K., Kaplan J.B., Furgang D., Legarda D., Diamond G., Parkin R.E., Fine D.H. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontits. Infect Immun 2003; 71: 6141-6147.
Wakabayashi H., Abe S., Teraguchi S., Hayasawa H., Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother 1998; 42: 1587-1591.
Wakabayashi H., Kondo I., Kobayashi T., Yamauchi K., Tbida T., Iwatsuki K., Yoshie H. Food Science and Technology Institute, Morinaga Milk Industry Co., Ltd, 5-1-83 Higashihara, Zama, Biometals 2010.
Wakabayshi H., Yamauchi K., Takase M. Int Dairy J 2006; 16: 1241-1246.
Wakabayashi H., Yamauchi K., Kobayashi T., Yaeshima T., Iwatsuki K., Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 2009; 53: 3308-3316.
Ward R.R., Paz E., Conelly O.M. Cell Mol Life Sci 2005; 62: 2540-2548.
Xu Y.Y., Samaranayake Y.H., Samaranayake L.P., Nikawa H. In vitro susceptibility of Candida species to lactoferrin. Med Mycol 1999; 37: 35-41.
Gerbert F. Vol'f, Edit M. Rateitskhak, Klaus Rateitskhak. Parodontologiya. Per. s nem. Pod red. prof. G.M. Barera. M: MEDpress-inform 2008; 548.
Grudyanov A.I., Fomenko E.F. Primenenie bakteriinykh preparatov v praktike parodontologii (obzor literatury). Novoe v stomatologii 2004; 4: 120.